One hundred percent of the Organization’s time is allocated to the achievement of the Organization’s tax-exempt purpose.
Ethos Discovery is a 501(c)3 nonprofit organization created by doctors associated with Ethos Veterinary Health, LLC in December 2016 to conduct nonprofit scientific research that will advance veterinary and human medical science. Led by Dr. Chand Khanna, Ethos Discovery is devoted to developing innovations that will improve the outcome for pets and humans afflicted with complex medical problems.
Ethos Discovery’s scientific strategy focuses on identifying areas of unmet need in collaboration with clinical teams within Ethos Veterinary Health. The leadership of Ethos Discovery then aligns these needs with academic and institutional nonprofit and commercial collaborators around the world. We are agnostic to the source of good ideas and welcome collaborators from different fields. Subsequent clinical studies are expected to deliver information to serve these unmet needs, and thus determine the value of these novel opportunities.
Our efforts began in the area of oncology (i.e. cancer research), and have expanded to deliver innovations to all fields of veterinary medicine and surgery. As a scientific incubator, Ethos Discovery will conduct clinical studies involving pet animals with naturally occurring disease, instead of conventional preclinical animal models (i.e., mice with artificially-induced cancer). Clinical studies will answer basic questions about the value of the research findings, with the goal of deriving novel diagnostic and therapeutic opportunities.
The similarity of disorders in pets and humans is widely recognized and it is likely the innovations we are working on will be useful for human patients in the future. We will offer results from our studies free of charge, and without restriction, to parties interested in commercialization for human health. In doing so, Ethos Discovery hopes to contribute to the development of novel diagnostic and therapeutic innovations in both veterinary and human medicine.
In the event these potential innovations can be useful for future veterinary patients, Ethos Discovery will enter into agreements allowing Ethos Veterinary Health the right of first refusal to pursue commercialization.